Gyeonggi-do, South Korea

Da-Bin Yim

This inventor holds 1 USPTO granted patent. Top assignee: Industry-University Cooperation Foundation Hanyang University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Da-Bin Yim. Retrieved from https://idiyas.com/inventor/da-bin-yim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Da-Bin Yim: Innovator in Burn Treatment Solutions

Introduction

Da-Bin Yim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of burns. His innovative approach utilizes advanced materials to enhance healing processes.

Latest Patents

Da-Bin Yim holds a patent for a pharmaceutical composition designed for burn treatment. This composition comprises transition metal dichalcogenide (TMD) nanosheets as an active ingredient. The patent highlights the potential of TMD nanosheets in improving the efficacy of burn treatments.

Career Highlights

Yim is affiliated with the Industry-University Cooperation Foundation at Hanyang University. His work focuses on bridging the gap between academic research and practical applications in the pharmaceutical industry. His dedication to innovation has led to advancements in medical treatments.

Collaborations

Da-Bin Yim collaborates with esteemed colleagues, including Jong-ho Kim and Chul-Su Yang. Together, they work on various projects aimed at enhancing the effectiveness of medical treatments through innovative research.

Conclusion

Da-Bin Yim's contributions to burn treatment through his patented pharmaceutical composition demonstrate his commitment to advancing medical science. His work not only showcases his inventive spirit but also holds promise for improving patient care in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…